Skip to main content

Table 1 The demographic and clinical characteristics of study participants

From: Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment

Group ATB LTBI (n = 10) HC (n = 10)
Total (n = 24) PTB (n = 14) TBP (n = 10)
Age, median (IQR) 40.5 (37) 35 (29.25) 49 (49) 50.5 (32.75) 43.5 (26)
Male, n (%) 18 (75) 9 (64.3) 9 (90) 3 (30) 1 (10)
BCG vaccination, n (%) 18 (75) 10 (71.4) 8 (80) 8 (80) 9 (90)
Culture positive, n (%) 11 (45.8) 6 (42.9) 5 (50)
Xpert MTB/RIF positive, n (%) 4 (16.7) 3 (21.4) 1 (10)
Confirmed TB by pathology, n (%) 2 (8.3) 2 (20)
Co-morbidity, n (%)      
 Diabetes 1 (4.2) 1 (10)
 Hypertension 3 (12.5) 2 (14.3) 1 (10)
 Arrhythmia 1 (4.2) 1 (7.1)
  1. ATB active tuberculosis, PTB pulmonary tuberculosis, TBP tuberculous pleurisy, LTBI latent tuberculosis infection, HC healthy controls, BCG bacillus Calmette-Guerin, TB tuberculosis